Glantus Holdings PLC Form 8.1 (3873F)
July 07 2023 - 8:55AM
UK Regulatory
TIDMGLAN
RNS Number : 3873F
Glantus Holdings PLC
07 July 2023
Ap9
APPENDIX 3
DISCLOSURE FORMS
FORM 8.1(a) & (b)
(Opening Position Disclosure)
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE
IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR
OR AN OFFEREE
1. KEY INFORMATION
(a) Full name of discloser: Glantus Holdings plc
(b) Owner or controller of interests and short positions disclosed, if different from N/A
1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s),
settlor and beneficiaries must be named.
---------------------
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Glantus Holdings plc
Use a separate form for each offeror/offeree
---------------------
(d) Is the discloser the offeror or the offeree? OFFEREE
---------------------
(e) Date position held: 4 July 2023
The latest practicable date prior to the disclosure
---------------------
(f) In addition to the company in 1(c) above, is the discloser also making disclosures N/A
in
respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
---------------------
2. INTERESTS AND SHORT POSITIONS
If there are interests and positions to disclose in more than
one class of relevant securities of the offeror or offeree named in
1(c), copy table 2 for each additional class of relevant
security.
Ap10
Interests and short positions in the relevant securities of the
offeror or offeree to which the disclosure relates (Note 1)
Class of relevant security: (Note 2)
Interests Short positions
----------- -----------------
Number % Number %
-------- -------------
(1) Relevant securities owned and/or controlled: Nil - Nil -
-------- -------------
(2) Cash-settled derivatives: Nil - Nil -
-------- -------------
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell: Nil - Nil -
-------- -------------
Total: Nil - Nil -
-------- -------------
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new
securities and any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8.
3. INTERESTS AND SHORT POSITIONS OF PERSONS ACTING IN CONCERT
WITH THE PARTY MAKING THE DISCLOSURE
Details of any interests and short positions (including directors' and other employee options)
of any person acting in concert with the party making the disclosure:
Name Number of % of total
Ordinary issued
Shares held share capital
Barry Townsley, - -
Non-Executive
Chairman
------------- ---------------
Maurice Healy,
Chief Executive
Officer 12,835,243 25.10
------------- ---------------
Geoff Keating,
Chief Technology
Officer 4,592,265 8.98
------------- ---------------
Tom Price, - -
Non-Executive
Director
------------- ---------------
Thomas Brooke, - -
Non-Executive
Director
------------- ---------------
No share options were in place for any person acting in concert with the Company including
Executive Directors and Non-Executive Directors.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8.
Ap11
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the party to the offer making the disclosure or any person acting
in concert with it:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative referred to on this form is referenced.
If none, this should be stated.
None
(c) Attachments
Is a Supplemental Form 8 attached? NO
Date of disclosure: 7 July 2023
Contact name: Maurice Healy, Chief Executive Officer
--------------------------------------
Telephone number: + 353 862677800
--------------------------------------
Public disclosures under Rule 8.1 of the Rules must be made to a
Regulatory Information Service.
Ap12
NOTES ON FORM 8.1(a) and (b)
1. See the definition of "interest in a relevant security" in
Rule 2.5 of Part A of the Rules and see Rule 8.6(a) of Part B of
the Rules.
2. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.
3. If details included in a disclosure under Rule 8 are
incorrect, they should be corrected as soon as practicable in a
subsequent disclosure. Such disclosure should state clearly that it
corrects details disclosed previously, identify the disclosure or
disclosures being corrected, and provide sufficient detail for the
reader to understand the nature of the corrections. In the case of
any doubt, the Panel should be consulted.
For full details of disclosure requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish
Takeover Panel Act, 1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ITPEAAXXESADEFA
(END) Dow Jones Newswires
July 07, 2023 08:55 ET (12:55 GMT)
Glantus (LSE:GLAN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Glantus (LSE:GLAN)
Historical Stock Chart
From Jul 2023 to Jul 2024
